Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Thursday, October 18, 2018 · 465,464,793 Articles · 3+ Million Readers

Global Biosimulation Systems Market is estimated to reach $6 Billion by 2025; growing at a CAGR of 4.13% from 2016 to 2025

LAS VEGAS, Nov. 07, 2017 (GLOBE NEWSWIRE) -- The Global Biosimulation Market was evaluated over USD 4.17 billion in 2016 and is anticipated to approximately reach USD 6.00 billion by 2025 while registering a compound annual growth rate (CAGR) of 4.13% over the forecast period. Biosimulation is a procedure wherein computer programs are employed for the biological processes’ simulation. Biosimulation has extensive reaching applications in the area of discovery of new drug and development existing drugs. It is a technique utilized for prognostication and biosimulation is utilized to forecast the future results of existing experiments linked invention and progress of new drugs. The practice of drug discovery as well as development is an expensive one, and the drug molecule’s failure in the recent drug development phase interprets into a huge wastage of money and time along with other resources. Thus, there is a requirement of a prognostic tool that will assist in forecasting the future results of drug development by imitation of the biological processes concerned. This is the most significant factor fueling the global biosimulation industry. The other factors backing up the biosimulation market growth are the rising spending on healthcare and development of improved technology related to simulation and advanced software.

Driver and Restraints of Biosimulation Market

The rising use of pharmacodynamics and pharmacokinetic (PK/PD) modeling in the pre-clinical expansion is anticipated to support the growth of the market considerably in the approaching years. The growing demand for superior technologies to trim down the cost obtained in drug discovery as well as development is the major factor assisting the market’s growth. Additionally, the amplified healthcare expenditure, enhanced simulation, and the introduction of advanced computer technologies and modeling tools boost the global biosimulation market growth. Also, growth in the level of prediction accuracy before actual drug trial is also fueling the growth of the global market. In spite of experiencing optimistic opportunities, the deficiency of appropriate standardization in the biosimulation field has been persistent to be a key reason for concern. Further, factors like insufficient knowledge regarding biological systems and processes and the probability of drug failure in biosimulation present a risk to the global market. However, in the future, the global market will be able to alleviate the most of the abovementioned concerns and display steady growth with the innovations on the card.

/EIN News/ -- Get Sample of Report:

Competitors and Market Classification

According to the application, the global market is divided into; Drug Discovery: Lead Identification, Lead Optimization, Target Identification, and Target Validation and Drug Development: Preclinical Testing and Clinical Trials, and In-Patient Validation. Geographically, the global biosimulation market is segmented in regions which are; Europe (Germany, Spain, Italy, France, UK and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia Pacific), North America (the United States, Mexico and Canada)and Rest of the World (Brazil, Saudi Arabia, South Africa, United Arab Emirates and Others).

Major Market Players

  • Certara L P.
  • Schrodinger LLC
  • ACD/Labs
  • Accelrys
  • Entelos
  • Simulation Plus Inc.
  • Physiomics plc
  • Rhenovia Pharma SAS
  • Insilico Biotechnology AG
  • LeadScope Inc.
  • Insilico biosciences Inc.
  • Genedata AG
  • Archimedes
  • Compugen Ltd.

Buy Report:

Table of Contents:
1. Introduction
2. Executive Summary
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers Rise in Incidence of Diabetes Rise in Aging Population High Rate of Drug Resistance
3.3.2. Restraints Lack of Standard Method for Biosimulation Lack of Knowledge and Unavailability of Skilled Professionals
3.3.3. Opportunities Continuous Rise in Demand for Advanced Software Programs Technological Advancements
3.4. Industry Trends
4. Biosimulation Market, By Technique
5. Biosimulation Market, By Application
6. Biosimulation Market, By Region
7. Company Profiles

About Crystal Market Research 
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us: 
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282

Powered by EIN News
Distribution channels: Consumer Goods
Submit your press release